Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 80.90 TWD
Change Today -1.80 / -2.18%
Volume 2.3M
As of 2:38 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

sci pharmtech inc (4119) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/3/15 - 84.00
52 Week Low
10/27/14 - 57.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SCI PHARMTECH INC (4119)

Related News

No related news articles were found.

sci pharmtech inc (4119) Related Businessweek News

No Related Businessweek News Found

sci pharmtech inc (4119) Details

SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and specialty chemicals in Taiwan. Its active pharmaceutical ingredients include allopurinol, amobarbital, probucol, pentobarbital sodium, thiopental, valproic acid, sodium valproate, divalproex sodium, bisoprolol hemifumarate, and propafenone products. The company also provides custom manufacturing services. The company was founded in 1987 and is based in Taoyuan, Taiwan.

Founded in 1987

sci pharmtech inc (4119) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sci pharmtech inc (4119) Key Developments

SCI Pharmtech, Inc. Announces Cash Dividend Payable on August 18, 2015

SCI Pharmtech, Inc. announced cash dividends of TWD 228,883,034. Record date is August 3, 2015. The payment date of the cash distribution is August 18, 2015.

SCI Pharmtech, Inc. Appoints Chia-Chun Jay Chen as Member of Audit Committee & Remuneration Committee

SCI Pharmtech, Inc. appointed Professor Chia-Chun Jay Chen Department of Chemistry, National Taiwan Normal University, as member of Audit Committee & Remuneration Committee of the company, effective June 12, 2015.

SCI Pharmtech, Inc. Appoints Chia-Chun Jay Chen as Independent Director

SCI Pharmtech, Inc. approved the election of Professor Chia-Chun Jay Chen, Department of Chemistry, National Taiwan Normal University as the independent director at Shareholders' Meeting, effective June 12, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4119:TT 80.90 TWD -1.80

4119 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4119.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4119 Industry Range
Price/Earnings 22.7x
Price/Sales 3.7x
Price/Book 2.5x
Price/Cash Flow 19.8x
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SCI PHARMTECH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at